Cargando…

Efficacy and safety of evogliptin in the treatment of type 2 diabetes mellitus in a Brazilian population: a randomized bridging study

BACKGROUND: Evogliptin (EVO) is a potent and selective dipeptidyl peptidase-4 inhibitor (DPP4i) developed for the treatment of type 2 diabetes mellitus (T2DM). DPP4is are known to exhibit a better glucose-lowering effect in Asians compared to other ethnic groups. Once EVO’s clinical development prog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cercato, Cintia, Felício, Joao Soares, Russo, Luis Augusto Tavares, Borges, Joao Lindolfo Cunha, Salles, Joao, Muskat, Patricia, Bonansea, Teresa, Chacra, Antonio Roberto, Eliaschewitz, Freddy Goldberg, Forti, Adriana Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6923891/ https://www.ncbi.nlm.nih.gov/pubmed/31890041 http://dx.doi.org/10.1186/s13098-019-0505-z

Ejemplares similares

Osteoporosis treatment: the battle to be won
por: Borges, Joao Lindolfo C
Publicado: (2020)

Effect of Rifampicin on the Pharmacokinetics of Evogliptin in Healthy Volunteers
por: Shin, Yesong, et al.
Publicado: (2022)

The Effect of Evogliptin Tartrate on Controlling Inflammatory Pain
por: Cho, Pyung Goo, et al.
Publicado: (2023)

SUN-650 Body Composition Assessment in Clinical Practice: Use in Rheumatoid Arthritis and Hypogonadism
por: da Silva, Marina Sousa, et al.
Publicado: (2020)

MON-361 Late Diagnosis in Adult Form of Hypophosphatasia
por: da Silva, Marina Sousa, et al.
Publicado: (2020)

Concepts and clinical use of ultra-long basal insulin
por: Eliaschewitz, Freddy Goldberg, et al.
Publicado: (2016)

Influence of gastric emptying on the control of postprandial glycemia: physiology and therapeutic implications
por: Tambascia, Marcos Antonio, et al.
Publicado: (2014)

Degludec: the new ultra-long insulin analogue
por: Tambascia, Marcos Antonio, et al.
Publicado: (2015)

Protective Effects of Evogliptin on Steatohepatitis in High-Fat-Fed Mice
por: Kim, Jin Hyun, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Interaction Between Evogliptin and Pioglitazone in Healthy Male Subjects
por: Hwang, Inyoung, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects
por: Yoo, Hyounggyoon, et al.
Publicado: (2020)

Evogliptin Directly Inhibits Inflammatory and Fibrotic Signaling in Isolated Liver Cells
por: Seo, Hye-Young, et al.
Publicado: (2022)

Poor glycaemic control in Brazilian patients with type 2 diabetes attending the public healthcare system: a cross-sectional study
por: Viana, Luciana V, et al.
Publicado: (2013)

Efficacy of evogliptin and cenicriviroc against nonalcoholic steatohepatitis in mice: a comparative study
por: Wang, Zheng, et al.
Publicado: (2019)

Evogliptin Suppresses Calcific Aortic Valve Disease by Attenuating Inflammation, Fibrosis, and Calcification
por: Choi, Bongkun, et al.
Publicado: (2021)

Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism
por: Maeda, Sergio Setsuo, et al.
Publicado: (2018)

In Vitro Metabolic Pathways of the New Anti-Diabetic Drug Evogliptin in Human Liver Preparations
por: Jeong, Hyeon-Uk, et al.
Publicado: (2015)

BrazIliaN Type 1 & 2 DiabetEs Disease Registry (BINDER): longitudinal, real-world study of diabetes mellitus control in Brazil
por: de Almeida-Pititto, Bianca, et al.
Publicado: (2022)

Bioconcentration and Acute Intoxication of Brazilian Freshwater Fishes by the Methyl Parathion Organophosphate Pesticide
por: Bosco de Salles, João, et al.
Publicado: (2015)

The efficacy and safety of evogliptin for type 2 diabetes mellitus: A systematic review and meta-analysis
por: Tang, Qizhi, et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers
por: Kim, Dasohm, et al.
Publicado: (2023)

Music Preferences and Personality in Brazilians
por: Herrera, Lucia, et al.
Publicado: (2018)

Analyzing the importance of attributes for Brazilian consumers to replace conventional beef with cultured meat
por: de Oliveira, Gabriela Andrade, et al.
Publicado: (2021)

Health-related quality of life in people with type 1 Diabetes Mellitus: data from the Brazilian Type 1 Diabetes Study Group
por: Braga de Souza, Ana Carolina Contente, et al.
Publicado: (2015)

Effects of the Combination of Evogliptin and Leucine on Insulin Resistance and Hepatic Steatosis in High-Fat Diet-Fed Mice
por: Shin, Chang Yell, et al.
Publicado: (2021)

The Effect of Compression Pressure on the First Layer Surface Roughness and Delamination of Metformin and Evogliptin Bilayer and Trilayer Tablets
por: Kim, Sun Ho, et al.
Publicado: (2023)

Variants in the VDR Gene May Influence 25(OH)D Levels in Type 1 Diabetes Mellitus in a Brazilian Population
por: Ferraz, Rafaella S., et al.
Publicado: (2022)

Advances in GLP-1 treatment: focus on oral semaglutide
por: Eliaschewitz, Freddy G., et al.
Publicado: (2021)

Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM)
por: Bertoluci, Marcello Casaccia, et al.
Publicado: (2017)

Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
por: Rhee, Su-jin, et al.
Publicado: (2016)

Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Renal Fibrosis Caused by Unilateral Ureteral Obstruction in Mice
por: Kim, Mi-Jin, et al.
Publicado: (2020)

Effects of the Antidiabetic Drugs Evogliptin and Sitagliptin on the Immune Function of CD26/DPP4 in Th1 Cells
por: Yoon, Hyunyee, et al.
Publicado: (2021)

Effects of Evogliptin as Add on in Type 2 Diabetes (T2DM) Subjects Inadequately Controlled With Metformin and Glimepiride Combination
por: Guha, Shaibal
Publicado: (2021)

Evogliptin, a DPP-4 inhibitor, prevents diabetic cardiomyopathy by alleviating cardiac lipotoxicity in db/db mice
por: Pham, Trong Kha, et al.
Publicado: (2023)

New and Emerging Therapies for Osteoporosis
por: Lewiecki, E. Michael, et al.
Publicado: (2010)

Corrigendum to “New and Emerging Therapies for Osteoporosis”
por: Lewiecki, E. Michael, et al.
Publicado: (2017)

Musical preferences of Brazilian high school students
por: Lorenzo-Quiles, Oswaldo, et al.
Publicado: (2020)

Proposal of an obesity classification based on weight history: an official document by the Brazilian Society of Endocrinology and Metabolism (SBEM) and the Brazilian Society for the Study of Obesity and Metabolic Syndrome (ABESO)
por: Halpern, Bruno, et al.
Publicado: (2022)

Mental distress in workers at two metallurgical companies in the state of São Paulo, Brazil
por: Felício, Phelipe Monteiro, et al.
Publicado: (2021)

Correction: Musical preferences of Brazilian high school students
por: Lorenzo-Quiles, Oswaldo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pf5vpjl8qgl0kfpli9pvlrsi0j